These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3087293)

  • 1. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
    Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
    Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study].
    Yamamura Y; Yasue M; Nakazato H; Ota K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):541-8. PubMed ID: 3923941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative immunochemotherapy for gastric cancer combined with perifocal administration of OK-432].
    Mukai M; Yamazaki Y; Amano H; Hiura T; Oda S; Namiki S; Nakajima K; Nagao K
    Gan To Kagaku Ryoho; 1984 May; 11(5):1071-7. PubMed ID: 6426402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer].
    Mori N; Hamada H; Nakamura T; Tanaka A; Nakajima I; Nakamura Y; Wada T; Yasutomi M
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3473-6. PubMed ID: 2508570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
    Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Tsuji H; Furusawa M; Tomita M; Taguchi T; Kosaki G; Iwanaga T; Hioki K; Kondo T; Yura J; Hirano M; Miura K; Izuo M; Takemiya S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2148-60. PubMed ID: 6820891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on the effect of adjuvant immunochemotherapy using OK-432 and 5-FU in pharyngeal and laryngeal cancers].
    Yajin K; Harada Y; Tagashira N; Suzuki M; Hirakawa K; Sera K; Nakata M; Takebayashi S; Okazaki H; Yashiki T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1921-7. PubMed ID: 3289502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric carcinoma: curative resection and adjuvant chemotherapy.
    Carrillo Hernández JF; Ernesto de Obaldía Castillo G; Ramírez Ortega C; Frías Mendivil M; Pardo M
    Arch Med Res; 1994; 25(1):29-35. PubMed ID: 8019111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer].
    Imaizumi M; Kondo T; Kamei H; Ichihashi H
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):60-8. PubMed ID: 6421243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative combination therapy involving local administration of a non-specific immunoactivated preparation (OK-432) and chemotherapeutic preparations for patients with stomach cancer].
    Mukai M; Ryu S; Kikuchi T; Ariga T; Nagashima T; Koh Z; Yamazaki Y; Odaka M; Satoh H; Nagao K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):880-6. PubMed ID: 3920972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group])].
    Imaizumi M; Kondo T; Kamei H; Ichihashi H
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2397-403. PubMed ID: 2124433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
    Sakata Y; Munakata A; Baba T; Saitoh S; Itoh T; Tamura Y; Furukohori N; Suzuki H; Kimura T; Kawata K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2065-71. PubMed ID: 3134859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological approach and surgical treatment of cancer].
    Nakazato H
    Gan No Rinsho; 1983 Oct; 29(13):1537-44. PubMed ID: 6422096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
    Sakata Y; Yoshida Y; Komatsu Y; Sugawara K; Nishimura S; Kikuchi K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
    Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.